WO2002020067A2 - Multi-layer absorbent wound dressing - Google Patents
Multi-layer absorbent wound dressing Download PDFInfo
- Publication number
- WO2002020067A2 WO2002020067A2 PCT/US2001/026791 US0126791W WO0220067A2 WO 2002020067 A2 WO2002020067 A2 WO 2002020067A2 US 0126791 W US0126791 W US 0126791W WO 0220067 A2 WO0220067 A2 WO 0220067A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- layer
- wound dressing
- absorbent
- absorbent layer
- wound
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B27/00—Layered products comprising a layer of synthetic resin
- B32B27/06—Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B7/00—Layered products characterised by the relation between layers; Layered products characterised by the relative orientation of features between layers, or by the relative values of a measurable parameter between layers, i.e. products comprising layers having different physical, chemical or physicochemical properties; Layered products characterised by the interconnection of layers
- B32B7/02—Physical, chemical or physicochemical properties
Definitions
- the present invention is directed to novel body fluid absorbing materials; and to absorbent articles used as wound dressings, including multi-layer absorbent articles having at least two absorbent layers.
- Proper wound dressings are an essential medical supply for treating injuries. Without dressings, the wound exudate accumulates and creates breeding grounds for harmful microorganisms. Each year, sterile wound dressings are applied to millions of wounds in order to absorb wound exudate while promoting sterility.
- Efforts have been made to improve upon these traditional wound dressings by applying a non-stick ' perforated film to the wound-facing side of the dressing.
- These nonstick films are designed to allow wound exudate to penetrate to the absorbent, while restricting the physical contact between the absorbent and wound in an effort to reduce undesirable adherence between the two.
- these perforated films do nothing to improve on the absorbency of traditional absorbent materials used in dressings.
- various alternative absorbent materials have been developed. For example, hydrophilic hydrocolloids and hydrogels have been created that provide a translucent or transparent absorbent layer. Such dressings can allow for general inspection of the healing wound. Unfortunately, some such dressings have the problem that the absorbent deforms and partially disintegrates upon swelling.
- the absorbent takes in fluid, it often bends and buckles such that some of the absorbent material breaks away from the dressing and enters the wound.
- This absorbent material can be left in the wound upon removal of the dressing, which is undesirable for cosmetic and therapeutic reasons, hi addition, such materials often have relatively high moisture content prior to application, which can limit their ability to absorb additional water after they are applied. Therefore, a need exists for a wound dressing that improves on existing dressing materials and technology.
- the present invention is directed to multi-layer wound dressings.
- the multi-layer wound dressings allow for high absorbency of body fluids while providing good durability and minimal degradation during use.
- the multilayer wound dressings are transparent and remain transparent when wet; and the dressings can be cut by clinicians to conform to the shape and size of the wound being covered.
- novel compositions useful as body fluid absorbing materials include at least two absorbent layers: a first absorbent layer and a second absorbent layer.
- the first absorbent layer is typically more absorbent than the second absorbent layer, and can retain a greater volume of body fluids than the second absorbent layer.
- the second absorbent layer is positioned such that it is located between the first absorbent layer and the wound. This second absorbent layer provides integrity to the wound dressing and avoids transfer of the first absorbent layer into the wound.
- the first absorbent layer typically contains the reaction product of a hydrophilic, ethylenically unsaturated monomer.
- the first absorbent layer includes the reaction product of a hydrophilic, ethylenically unsaturated monomer; an acrylic acid ester of a non-tertiary alcohol having 4 to 14 carbon atoms; and a polar, ethylenically unsaturated monomer.
- the first absorbent layer can contain the reaction product of about 50 to 80 parts by weight of the hydrophilic, ethylenically unsaturated monomer; about 5 to 30 parts by weight of the acrylic acid ester of the non- tertiary alcohol having from 4 to 14 carbon atoms; and about 10 to 40 parts by weight of the polar, ethylenically unsaturated monomer.
- the polar, ethylenically unsaturated monomer comprises N- vinyl acetamide or partially neutralized acrylic acid in specific implementations.
- compositions including absorbent layers and body fluid absorbing materials comprising the reaction product of various parts by weight of specific monomers that the total monomer composition is 100 parts.
- the second absorbent layer is typically positioned in contact with the first absorbent layer and is typically less absorbent of body fluids than the first absorbent layer.
- the second absorbent layer can also contain the reaction product of an acrylic acid ester of a non-tertiary alcohol having from 4 to 14 carbon atoms; a hydrophilic, ethylenically unsaturated monomer; and a polar, ethylenically unsaturated monomer, hi particular implementations, the second absorbent layer contains the reaction product of about 45 to
- the first and second layers are usually formed such that they are in contact with one another across a large surface area.
- the absorbent layers are formed by a simultaneous polymerization reaction, h such implementations, the unpolymerized monomer can be deposited simultaneously or sequentially and then cured together. Such simultaneously cured absorbent materials often show enhanced physical integrity because they form a strong interface. It is believed that such strength may be a result of some slight interfacial mixing of the layers prior to and during curing.
- the second absorbent layer functions as a "barrier” between the first absorbent layer (which may partially “disintegrate” when exudate is absorbed under some conditions) and the wound.
- the second absorbent layer has adhesive properties (or is a pressure sensitive adhesive) and functions to enhance the overall integrity of the wound dressing.
- the second absorbent layer ties the first absorbent layer to a wound-facing layer (or to the wound itself). By having adhesive properties, this second absorbent layer not only aids in controlling the absorption of exudate, but also physically joins to other components of the dressing.
- the first absorbent layer is typically significantly more absorbent than the second absorbent layer, and preferably has an absorbency at least 100 percent greater than the absorbency of the second absorbent layer.
- the first absorbent layer preferably absorbs at least 400 percent of its weight after immersion in an isotonic saline solution after 24 hours at room temperature.
- the second absorbent layer normally has an absorbency of at least about 50 percent by weight of isotonic saline solution after 24 hours.
- absorbency refers to the percent by weight of isotonic saline solution absorbed by a material tested according to the Saline Absorbency Method described herein.
- Additional layers such as backing layers, wound-facing layers, and adhesives are also suitable for use in certain implementations of the invention.
- the invention is also directed to methods of making multi-layer wound dressings, including multi-layer wound dressings in which two or more layers of absorbent are simultaneously cured.
- dressings of the invention can include various materials, the invention is also directed to specific absorbent compositions for use in wound dressings. These compositions include materials containing the reaction product of partially neutralized ethylenically unsaturated carboxylic acids and materials containing the reaction product of N- vinyl acetamide.
- Figure 1A is a top view of a first wound dressing constructed in accordance with the present invention.
- Figure IB is a partial cross-sectional view taken along plane A-A' of the wound dressing from Figure 1 A.
- Figure 1 C is a partial cross-sectional view of a second wound dressing constructed in accordance with the present invention.
- the present invention is directed to multi-layer wound dressings that allow for high absorbency of wound exudate.
- the wound dressings contain absorbent layers that demonstrate low disintegration after absorbing body fluids such that absorbent material does not significantly enter the wound, h addition, in specific implementations, the wound dressings are substantially transparent before and after placement on a wound (with the exception of colored exudate, such as blood), and are formed such that they can be cut to custom sizes by clinicians prior to placement on a wound.
- a top view is shown of a wound dressing 10 constructed in accordance with a first implementation of the invention. Wound dressing 10 is shown adhered on the surface of a patient. Dressing 10 is substantially transparent, with a portion of the wound 14 visible through the top surface 16 of dressing 10.
- transparency refers to dressings that permit viewing of material through the dressing with sufficient clarity to perform general visual examinations.
- the dressings are substantially transparent when the dressings are dry or wet with water or wound exudate. Such transparency typically shows some optical distortion and may include loss in detail and resolution. Also, to the extent the wound exudate is colored by blood or other fluids, the transparency of the dressing is reduced.
- FIG. IB is a partial cross section of the wound dressing 10 taken along plane A-A' of Figure 1A.
- Wound dressing 10 includes six layers: A backing layer 20, an adhesive layer 22, a first absorbent layer 24, a second absorbent layer 26, a porous or non-continuous wound- facing layer 28; and a pressure sensitive adhesive 30.
- the first and second absorbent layers 24, 26 are positioned only within the interior of dressing 10, while the other four layers extend along the entire dressing 10, and thereby form a perimeter of substantially non-absorbent material. This perimeter can be advantageous because it provides a border and frame for the absorbent layers.
- the multiple layers of the dressing 10 extend to the edges of the dressing and thus provide a dressing that can conveniently be cut to size, h the dressing 10 shown in Figure 1C, the second absorbent layer 26 is substantially adhesive and provides a bond between the first absorbent layer 24 and the wound-facing layer 28.
- the multiple layers of wound dressing 10 are held together independent of any edge or frame bonds.
- This type of wound dressing is particularly well suited to being cut by a clinician to conform to a custom shape because the wound dressing does not delaminate, or delaminates only an acceptable amount, upon exposure to wound exudate.
- These multi-layer wound dressings show favorable abso ⁇ tion of exudate from wounds while also providing an integrated dressing that avoids significant shedding of the absorbent layers into the wound dressing.
- the present invention features a first absorbent layer comprised of an absorbent composition that is capable of rapidly absorbing moderate to heavy amounts of body fluids, while retaining sufficient structural integrity and transparency.
- This first absorbent layer typically is the most absorbent material of the dressing.
- the composition of the first absorbent layer typically includes the reaction product of:
- Suitable acrylic and methacrylic acid ester monomers include esters prepared by reaction with alcohols, such as 1-butanol, 2-butanol, 1-pentanol, 2-pentanol,
- the acrylic or methacrylic acid ester is selected from the group consisting of isooctyl acrylate, 2-ethyl hexyl acrylate, isodecyl acrylate, lauryl acrylate, nopol acrylate, and combinations thereof.
- the amount of the acrylic or methacrylic acid ester typically is less than 80 parts by weight, preferably less than 50 parts by weight, more preferably 5 to 30 parts by weight, and most preferably 10 to 25 parts by weight.
- suitable hydrophilic, ethylenically unsaturated monomers include free radically reactive hydrophilic oligomers (a polymer having a low number of repeating units, generally 2 to 20) and/or polymers including poly(alkylene oxides) (e.g., poly(ethylene oxide)), poly( vinyl methyl ether), poly(vinyl alcohol), cellulose derivatives, and mixtures thereof.
- suitable hydrophilic, ethylenically unsaturated monomers include macromonomers, e.g., acrylate-terminated poly(ethylene oxide), methoxy poly(ethylene oxide) acrylate, butoxy poly(ethylene oxide) acrylate, p-vinyl benzyl- terminated polyethylene oxide), acrylate-terminated poly(ethylene glycol), methacrylate- terminated poly(ethylene glycol), methoxy poly(ethylene glycol) methacrylate, butoxy poly(ethylene glycol) methacrylate, p-vinyl benzyl-terminated poly(ethylene glycol), poly(ethylene oxide) diacrylate, poly(ethylene oxide) dimethacrylate, and combinations thereof.
- macromonomers e.g., acrylate-terminated poly(ethylene oxide), methoxy poly(ethylene oxide) acrylate, butoxy poly(ethylene oxide) acrylate, p-vinyl benzyl- terminated polyethylene oxide), acrylate-terminated poly(ethylene glycol), methoxy poly
- the hydrophilic, ethylenically unsaturated monomer can be acrylate and methacrylate esters prepared from mono-hydroxyl-terminated poly(lower alkylene oxides) such as polyethylene and polypropylene glycols commercially available under the trade designation Carbowax from Union Carbide Corp. in a variety of molecular weights (e.g.,
- the hydrophilic, ethylenically unsaturated monomer preferably is selected from the group consisting of acrylate-terminated poly(alkylene oxides) and methacrylate-terminated poly(alkylene oxides).
- a preferred monomer is an acrylate-terminated methoxy poly(ethylene glycol) monomer.
- the amount of the hydrophilic, ethylenically unsaturated monomer typically is between 30 and 100 parts by weight, and more typically 50 to 80 parts by weight.
- the polar, ethylenically unsaturated monomer preferably is selected from the group consisting of partially neutralized acrylic acid, methacrylic acid, itaconic acid, N- vinyl acetamide, N-methyl-N- vinyl acetamide, N- vinyl propionamide, trialkylaminoethyl(meth)acrylate salt such as trimethylaminoethyl acrylate chloride, N- vinyl-pyrrolidone, N-vinylcaprolactam, hydroxyethyl (meth)acrylate or N- (acryloyloxyethyl)pyrrolidinone; with partially neutralized acrylic acid and N- vinyl acetamide being preferred.
- the amount of the polar, ethylenically unsaturated monomer preferably is between 0 and 40 parts by weight, more preferably 10 to 30 parts by weight, and most preferably 15 to 25 parts by weight.
- An example of a preferred absorbent composition is one that includes the reaction product of lauryl acrylate, acrylate-terminated methoxy poly(ethylene glycol), and partially neutralized acrylic acid or N- vinyl acetamide.
- the composition used to form the first absorbent layer preferably is tacky after curing and capable of absorbing at least about 200%, more preferably at least about 400%, and most preferably at least about 600% by weight isotonic saline after 24 hours while substantially retaining- its structural integrity and transparency. Thus, the first absorbent layer is highly absorbent.
- Acrylic acid, methacrylic acid, and itaconic acid contain carboxylic acid group(s), which can react with a base such as sodium hydroxide.
- a base such as sodium hydroxide.
- the acrylic acid is neutralized or fully neutralized.
- a mole of acrylic acid is partially neutralized when it reacts with less than one mole of sodium hydroxide.
- an acid is partially neutralized when one equivalent of acid reacts with less than an equivalent of base.
- a ethylenically unsaturated carboxylic acid containing monomer is used in a composition of this invention, it is typically partially neutralized from 1 to 49%.
- the carboxylic acid containing monomer composition is 17% partially neutralized. Neutralization above 49% does not typically produce a clear monomer solution without the addition of a large amount of water.
- the second absorbent layer is also typically absorbent, but less absorbent than the first layer.
- the second layer may contain the same components as described above for the first absorbent layer, however it preferably consists of a higher concentration of the acrylic or methacrylic acid ester monomer and is more tacky.
- the composition preferably includes the reaction product of:
- a hydrophilic, ethylenically unsaturated monomer (b) 25 to 40 parts by weight of a hydrophilic, ethylenically unsaturated monomer; and (c) 2 to 20 parts by weight of a polar, ethylenically unsaturated monomer different from the hydrophilic, ethylenically unsaturated monomer, such as partially neutralized carboxylic acid containing monomer; trialkylaminoethyl (meth)acrylates such as trimethylaminoethyl acrylate chloride; N-vinyl amides such as N-vinyl acetamide, N- methyl-N- vinyl acetamide, and N-vinyl propionamide; N-vinyl lactams such as N-vinyl pyrolidinone and N-vinylcaprolactam, hydroxyethyl acrylate, hydroxyethyl methacrylate, or N-(acryloyloxyethyl)pyrroli
- the composition of the second absorbent layer comprises 55 to 70 parts by weight of an acrylic or methacrylic acid ester of a non-tertiary alcohol having between 4 and 14 carbon atoms, inclusive; 30 to 35 parts by weight of a hydrophilic, ethylenically unsaturated monomer; and 4 to 15 parts by weight of a polar, ethylenically unsaturated monomer different from the hydrophilic, ethylenically unsaturated monomer.
- the second absorbent layer preferably functions as a pressure sensitive adhesive, and can control the rate of exudate influx into the first absorbent layer.
- the exudate absorbency of the second absorbent layer is typically lower than the exudate absorbency of the first absorbent layer.
- the exudate absorbency of the second absorbent layer is 2-fold lower than the exudate absorbency of the first absorbent layer. More preferably, ' the exudate absorbency of the second absorbent layer is 3-fold lower than the exudate absorbency of the absorbent layer.
- the first and second absorbent layers combine to provide favorable absorbency and integrity.
- the first absorbent layer typically has the greatest capacity for absorbing exudate, but the second absorbent layer aids in providing integrity to the first absorbent, layer.
- integrity is aided depending upon the implementation, by providing a physical barrier, an absorption rate control layer, and/or a physical strengthening layer, hi a first regard, the second layer serves as a barrier because it is more durable than the first layer when fully saturated (in part because it is able to absorb less liquid).
- the lower absorbency of the second absorbent layer helps to regulate the rate of liquid uptake in the first layer.
- the first layer can uniformly swell and show less disintegration, hi a third regard, the second layer, particularly when it has adhesive properties, secures the portions of the dressing together, thereby adding strength.
- the first absorbent layer is typically from 5 to 100 mils thick, and more typically from 10 to 50 mils thick, h specific preferred implementations, the first absorbent layer is 20 to 30 mils thick, and more preferably about 25 mils thick.
- the second absorbent layer is typically less than 50 mils thick, and more typically from 1 to 10 mils thick. In specific implementations, the second absorbent layer is from 2 to 4 mils thick, including implementations having a second absorbent layer that is 3 mils thick.
- the first absorbent layer is at least as thick as the second absorbent layer, and more typically significantly thicker than the second absorbent layer.
- the first layer can be up to 50 times thicker than the second layer in specific example embodiments.
- the thickness of the first layer is from 2 to 15 times the thickness of the second layer, and more typically from 5 to 10 times greater.
- the first absorbent layer is about 8 times the thickness of the second absorbent layer.
- multifunctional crosslinking monomers may be included in the preparation of the absorbent layers.
- multifunctional refers to crosslinking monomers which have two or more free radically polymerizable, ethylenically unsaturated groups.
- Useful multi-functional crosslinking monomers include acrylic or methacrylic esters of diols, including 1,4-butanediol diacrylate, 1,4-butanediol dimethacrylate, neopentyl glycol diacrylate, 1,6-hexanediol diacrylate, 1,6-hexanediol dimethacrylate; acrylic or methacrylic esters of triols such as glycerol; and tetraols such as pentaerythritol.
- polymeric multifunctional (meth) acrylates e.g., alkylene glycol-type diacrylates or dimethacrylates, such as diethylene glycol diacrylate, diethylene glycol dimethacrylate, triethylene glycol diacrylate, diethylene glycol dimethacrylate, polyethylene glycol 200 diacrylate, polyethylene glycol 400 diacrylate, polyethylene glycol 600 diacrylate, polyethylene glycol
- polymeric multifunctional (meth) acrylates e.g., alkylene glycol-type diacrylates or dimethacrylates, such as diethylene glycol diacrylate, diethylene glycol dimethacrylate, triethylene glycol diacrylate, diethylene glycol dimethacrylate, polyethylene glycol 200 diacrylate, polyethylene glycol 400 diacrylate, polyethylene glycol 600 diacrylate, polyethylene glycol
- the polymerization reaction may be initiated using various methodologies, including photoinitiation, chemical initiation (such as using peroxide), and thermoinitiation.
- photoinitiation the amount of photoinitiator used in the monomer mixture differs according to the extinction coefficient thereof, but typically ranges from about 0.001 to about 5.0 parts by weight per 100 parts of total monomer, preferably from about 0.01 to about 5.0 parts by weight, and more preferably from about 0.05 to about 0.5 parts by weight.
- Useful photoinitiators include acetophenone, 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-l- [4-(hydroxyethoxy)phenyl] -2-methyl- 1-propanone, 2-hydroxy-2-methyl-l- phenylpropan-1-one, l-(4-isopropylphenyl)-2-hydroxy-2-methylpropan-l-one, l-(4- dodecylphenyl)-2-hydroxy-2-methylpropan- 1 -one, 4-(2-hydroxyethoxy)-phenyl-(2- hydroxy-2-propyl)ketone, 2-methyl- 1 -[4-(methylthio)phenyl] -2-morpholinopropane- 1 ; substituted alpha-ketols such as 2-methyl-2-hydroxypropiophenone; benzoin photopolymerization initiators such as benzoin, benzoin methyl ether, benzoin ethyl ether, benzoin propyl
- Other materials which may be added to the monomer mixture include chain transfer agents or chain stopping agents for controlling molecular weight (e.g., carbon tetrabromide, mercaptans, alcohols, methacrylates, vinyl compounds such as alpha-methyl styrene, or other monomers), tackifiers, perfumes, deodorants, and antioxidants.
- chain transfer agents or chain stopping agents for controlling molecular weight
- mercaptans e.g., carbon tetrabromide, mercaptans, alcohols, methacrylates, vinyl compounds such as alpha-methyl styrene, or other monomers
- tackifiers e.g., tackifiers, perfumes, deodorants, and antioxidants.
- the absorbent layers may also contain plasticizers.
- plasticizers suitable for use in the present invention are low molecular weight polyhydric alcohols such as ethylene glycol, diethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, glycerol, diglycerol, 2,3-butanediol, 1,2-butanediol, 3-methyl-l,3- butanediol, 3-methyl-l,3,5-pentanetriol, 2-ethyl- 1,2-hexanediol, polyethylene glycol, methoxypolyethylene glycol, polypropylene glycol, polyoxyethylene butyl ether, polyoxyethylene, polyoxypropylene, polyoxypropylene glyceryl ether, polyoxypropylene sorbitol, and polyoxyethylene polyoxypropylene pentaerythritol ether each having an average molecular weight of 1,000 or less.
- the plasticizers are typically selected such that they do not significantly
- the absorbent layers may be prepared by photoinitiated bulk polymerization according to the technique described in Martens et al., U.S. Pat. No. 4,181,752.
- the polymerizable monomers and photoinitiator are mixed together in the absence of solvent and partially polymerized to a viscosity in the range from about 500 to about 50,000 centipoise to achieve a c ⁇ atable syrup.
- the cross-linking agent (if needed) and any other ingredients are then added to the prepolymerized syrup.
- these ingredients can be added directly to the monomer mixture prior to pre-polymerization.
- a backing layer may be present in embodiments of the present invention.
- the backing layer is typically the layer farthest from the wound, and provides additional strength to the dressing.
- Preferably the backing layer is conformable to animal anatomical surfaces, and impermeable to liquid water.
- the backing layer can be a transparent, conformable, elastomeric, moisture vapor permeable film.
- the backing film is preferably impermeable to liquid water and has a moisture vapor transmission rate (MVTR) of at least 300 g per 24 hr at 37 °C and 80 % relative humidity. More preferably, the MVTR is at least 700 g per 24 hr at 37 °C and 80
- the backing will allow some moisture to evaporate from the dressing while still maintaining a moist environment, will prevent the wound from drying out, and will prevent bacteria and viral ingress. It is also desirable that the backing be a low friction material, such as that disclosed in U.S. Pat. No. 5,643,187.
- the dressing is preferably conformable to anatomical surfaces and stretches to accommodate flexion of joints and distension of skin. After the dressing stretches, ideally it has elastic properties so that the dressing returns to the same size as before stretching.
- the backing may have a thickness of from 15 to 100 micrometers, preferably 20 to 80 micrometers and more preferably 20 to 50 micrometers.
- the backing layer may further comprise a pressure sensitive adhesive layer to enhance adhesion to the first absorbent layer.
- Various materials can be used as the backing material.
- Specific examples include papers, non-woven fabrics, natural fiber (e.g., cotton) fabrics, synthetic resin fabrics, synthetic resin films, synthetic resin foams, mesh-form or network papers, woven fabrics, and knit fabrics.
- Surgical tapes, medical pressure-sensitive adhesive sheets, pressure-sensitive adhesive dressings, constructed with the above films, foams, non-woven fabrics, woven fabrics, or knits can also be used as a backing material.
- suitable backing materials include polyurethanes such as Estane polyurethanes (available for B.F. Goodrich, Cleveland, OH) including, for example,
- Other suitable backing materials include elastomeric polyester such as Hytrel polyester elastomer (E.I. duPont deNemours & Co., Wilmington, Del.), blends of polyurethane and polyester, and polyvinyl chloride.
- Thermoplastic polyether-amide block copolymers such as Pebax 2533 and Pebax 3533 (available from Atochem Co.); and polyether-ester block copolymers may also be used.
- the wound dressing of the present invention preferably comprises a porous or non- continuous wound-facing layer to provide a fluid permeable barrier between the wound site and the absorbent layers, but may be optionally non-porous or continuous.
- the wound-facing layer allows transport of moisture (i.e. fluid and vapor) from the wound to the absorbent layers and can help isolate the wound from other components of the dressing.
- the wound-facing layer is preferably soft, flexible, conformable, non-irritating and non-sensitizing.
- a variety of polymers may be used for the wound-facing layer, including polyurethane, polyethylene, polypropylene, polyamide or polyester materials.
- wound-facing layer may be in the form of moisture vapor permeable films, perforated films, woven-, non-woven or knit webs, or scrims.
- a preferred wound-facing layer comprises a polyurethane film.
- the wound-facing layer is conformable to animal (including human) anatomical surfaces, has a moisture vapor transmission rate of at least
- the wound-facing layer typically does not pass liquid water under normal wound treatment conditions except at the places in the wound-facing layer which are positively perforated to allow the exudate to pass into the absorbent layer.
- the preferred moisture vapor transmission rate of the wound-facing layer is at least 600 grams per square meter per 24 hours at an 80% relative humidity differential at 40° C.
- the wound-facing layer may further comprise a pressure sensitive adhesive layer.
- the adhesive coated wound-facing layer should have the aforesaid MVTR.
- Porous or non- porous wound-facing layers such as perforated polyurethane, polyamide, polyester, polypropylene, polyethylene, polyether-amide, polyurethanes, chlorinated polyethylene, styrene/butadiene block copolymers ("Kraton" brand thermoplastic rubber, Shell Chemical Company, Houston, Tex.) and polyvinyl chloride and those described in U.S. Pat. No. 3,121,021 that are covered with a pressure sensitive adhesive that is not permeable to liquid water can be used for the wound-facing layer.
- these films can be perforated.
- Additional porous materials include woven, knit, and non- woven substrates. It is also desirable that the wound-facing layer be a low friction material, such as that disclosed in U.S. Pat. No. 5,643,187.
- the wound-facing layer have the above mentioned moisture vapor or liquid permeability (1) so that maceration of the skin under the wound dressing does not occur or is minimized, (2) so that moisture build-up under the wound-facing layer does not cause the wound-facing layer and, therefore, the wound dressing to be lifted off the skin, and (3) to enhance proximation of the wound edges.
- Preferred wound-facing layers are thin polymeric films optionally coated with pressure sensitive adhesive which, in combination, have the above characteristics.
- the diameter of perforations or apertures in the wound-facing film are preferably less than the thickness of the two absorbent layers. More preferably, the diameter is less than 70% of the thickness of the absorbent layers. And still more preferably, the diameter is less than 60% of the thickness of the absorbent layers.
- the void area of the apertures is determined by measuring the average diameter of the apertures and then calculating the average aperture area. The number of apertures per unit area is also counted. Finally, the Percent Void Area is calculated by the equation:
- wound-facing film with a void area between 1 and 20%, more preferably between 3 and 10%, and most preferably between 4 and 8%. If the Percent Void Area is too low, the rate of fluid abso ⁇ tion will be slow. If the Percent Void Area is too high, the mechanical strength of the film will diminish to an unacceptable level.
- the wound-facing layer is normally attached to the wound site by means of an adhesive which can be continuous or non-continuous, such as pattern coated.
- Adhesives which can be used with the wound dressings of the invention include adhesives which are applied to the skin such as those described in U.S. Pat. No. Re. 24,906 (Ulrich), particularly a copolymer of 96% iso-octyl acrylate units and 4% acrylamide units and a copolymer of 94% iso-octyl acrylate units and 6% acrylic acid units.
- Other useful adhesives are those described in U.S. Pat. No.
- 3,389,827 that comprise block copolymers having three or more polymer block structures having a general configuration --A--B--A-- wherein each A is a thermoplastic polymer block with a glass transition temperature above room temperature (i.e., above about 20° C) having an average molecular weight between about 5000 and 125,000, and B is a polymer block of a conjugated diene having an average molecular weight between about 15,000 and 250,000.
- Additional examples of useful adhesives are acrylic adhesives such as iso-octyl acrylate/N-vinyl pyrrolidone copolymer adhesives and crosslinked acrylate adhesives such as for example those described in U.S. Pat. No. 4,112,213.
- the adhesive may optionally be a microsphere adhesive with low trauma properties as described in U.S. Pat. No. 5,614,310; a fibrous adhesive with low trauma properties as described in U.S. Pat. application Ser. No. 08/980,541, filed December 1, 1997; or have especially good adhesion to wet skin, such as the adhesives described in U.S. Pat. application Ser. No. 09/329,514, filed June 10, 1999; and PCT Publication Nos. WO
- the adhesive may be chosen to be permeable to water or wound exudate, or the adhesive may be pattern coated on the front surface of the wound dressing (i.e. the surface in contact with the wound site, whether it is the front surface of the facing or backing layers) so as to not impede the flow of exudate to the absorbent layer, i.e. the adhesive may be coated non-continuously or at the periphery of the wound dressing.
- the adhesive layer may be perforated as described for the facing film to provide a fluid path for the exudate.
- a release liner maybe attached to the adhesive layer for ease of handling.
- release liners are liners made of or coated with polyethylene, polypropylene and fluorocarbons and silicone coated release papers or polyester films.
- silicone coated release papers are Polyslik S-8004, 83 pound (135.4 g/m ⁇ ) bleached silicone release paper supplied by H. P. Smith Co., Chicago, 111., and 80 pound (130.5 g/m2) bleached two-sided silicone coated paper (2-80-BKG-l 57) supplied by Daubert Chemical Co., Dixon, 111.
- a pressure sensitive layer may also be optionally included between the backing and the first absorbent layer and can be made from medical grade adhesives and methods that are publicly known.
- Preferred adhesives are acrylate copolymers described in U.S. Pat. No. RE 24,906, particularly a 97:3 iso-octyl acrylate :acrylamide copolymer. Also preferred is a 70: 15 : 15 isooctyl acrylate: methoxypolyethyleneoxide acrylate: acrylic acid te ⁇ olymer as described in U.S. Pat. Nos. 4,737,410 (Example 31) and 5,849,325. Other useful adhesives are described in U.S. Pat. Nos.
- the backing adhesive may also serve as a border skin contact adhesive.
- the preferred embodiments for the facing and backing layers are thin conformable polymeric films. Generally the films are from 12 to 50 microns in thickness, preferably from 12 to 25 microns. Conformability is somewhat dependent on thickness, thus the thinner the film the more conformable the film.
- the wound dressing of the invention may also comprise a frame or film overlay that allows the dressing to be more easily applied to the wound.
- the frames are made of a relatively rigid material that maintains the shape of the dressing during handling and application to the wound site. Each frame is generally releasably adhered to the back surface of the backing film and is removed after application of the wound dressing. Suitable frames are described in U.S. Pat. Nos. 5,531,855 and 5,738,642 (Heinecke et al).
- composition of this invention may also contain one or more pharmaceutically active agents.
- pharmaceutically active agents are antibacterial agents such as povidone iodine, iodine, silver, silver chloride, and chlorhexidine.
- Pharmaceutically active agents can be used alone or as mixtures thereof; further, medicaments can be added before the reaction product of this invention is cured as long as they do not interfere with polymerization or the function or clarity of the finished dressing.
- Pharmacologically active agents can also be added after the reaction product is cured as they do not interfere with the function or clarity of the finished dressing.
- absorbent dressings are possible with the wound- facing layer, the absorbent layers and the backing layer.
- the areas of the wound-facing layer and the backing layer are greater than that of the absorbent layers, and the wound-facing layer is bonded to the backing layer, thereby forming a pouch, with the absorbent disposed between the two.
- the greater area of the facing or backing layer forms a periphery to which an adhesive layer and a release liner may be attached.
- the wound-facing, absorbent and backing layers of the present invention be at least translucent and more preferably sufficiently transparent so that the wound site to which they are applied can be viewed through the dressing. It is advantageous to view and evaluate the wound and healing thereof without removal of the wound dressing to avoid unnecessary handling of the wound site and exposure of the wound to the environment, which reduces the likelihood of contamination, and avoids the need to cleanse the wound as would be the case were the dressing to be removed.
- the dressing be both transparent and colorless so that the color of the wound, exudate, and periwound skin may also be evaluated.
- Preferred transparent films for use as facing and backing layers that allow visual inspection of the wound site include polyurethane films, such as ESTANETM polyurethanes (B.F. Goodrich, Cleveland, OH); elastomeric polyesters, such as HYTRELTM polyester elastomers (E. I. duPont deNemours & Co., Wilmington, Del) and polyether block amides (PEBAX, Elf Altochem North America, Philadelphia, PA).
- Other useful films are those described in U.S. Pat. Nos. 4,499,896; 4,598,004; and 5,849,325 (Heinecke et al.).
- the invention also features methods of treating an exuding wound that includes applying one of the above-described dressings to the wound and allowing the dressing to absorb body fluids exuded from the wound. Furthermore, the invention features transparent, elastomeric, body fluid-absorbing compositions that include the above- described reaction products and have the above-described properties.
- the invention features methods for preparing a transparent, elastomeric, body fluid-absorbing composition that includes exposing an essentially solvent-free mixture of monomers or pre-polymeric syrup to actinic radiation to form the composition.
- the mixture or syrup includes: (a) an acrylic or methacrylic acid ester of a non-tertiary alcohol having between 4 and 14 carbon atoms, inclusive; (b) a hydrophilic, ethylenically unsaturated monomer; and (c) a polar, ethylenically unsaturated monomer different from the hydrophilic, ethylenically unsaturated monomer.
- the resulting composition is essentially free of hydrocolloidal gel particles and capable of absorbing moderate to heavy amounts of body fluids while retaining its structural integrity and transparency.
- the mixture or syrup further includes a photoinitiator and is exposed to ultraviolet radiation.
- the absorbent layers of the wound dressing can be formed separately and then adhered together either with an adhesive composition or adhered using the inherent adhesive properties of the absorbent layers, or by inco ⁇ oration of an additional adhesive between the two layers.
- the two layers are simultaneously cured together. Such simultaneous curing can be accomplished by forming layers of uncured monomer and then curing together.
- the first layer of monomer can be deposited onto a surface, followed by deposit of the second layer of monomer, and concluded with curing of the two layers.
- the two layers of uncured monomer can be simultaneously deposited (such as by being coextruded) and then cured.
- a dry wound dressing sample (5-cm square) was weighed (W 0 ) and placed in a 180-ml bottle containing 50 ml of 0.9% Sodium Chloride Irrigation (isotonic saline solution) USP (Baxter Health Care Co ⁇ ., Deerfield EL) at room temperature. The bottle was capped and allowed to stand without agitation. The sample was removed at 24 hours, blotted dry, and weighed (W 24 ). The percent absorbency values were calculated using the following formula and the results reported as an average of three replications:
- a dry wound dressing sample (10 cm x 15 cm) was applied to the upper flange of a clear polycarbonate cup, similar to a Paddington cup as described in the British Pharmacopoeia, 1993, Addendum 1996, page 1943, HMSO London, England.
- the sample was positioned over the center of the cup cavity (3.8-cm diameter, 3 -cm depth, 14-ml volume capacity) and the sample was held in place by its own pressure sensitive adhesive layer.
- the cup was then inverted and 12 g of calf bovine serum (Sigma- Aldrich Chemical Co.) was added to the cup through a port. The port was closed with a threaded plug and the cup was placed in an incubator at 40° C and 20% RH.
- the peel force method was used to measure the force required to remove a wound- facing layer of an adhesive dressing sample from its core layer.
- a 2.54-cm wide double- coated adhesive tape (3M Brand Double Stick Tape, 3M Company, St. Paul, MN) was adhered to the full circumference of a rotatable metal wheel that was mounted on the lower jaw of an histron machine (Model No. 1122; Instron Co ⁇ ., Canton, MA).
- a 2.54-cm wide polyester silicone adhesive tape No. 8402 tape, 3M Company was adhered to the double-coated tape, adhesive side out.
- An adhesive dressing sample (2.54 cm x 10.2 cm) was placed on the silicone tape with the core layer facing against the wheel and the wound- facing layer facing the operator. One end of the wound-facing layer was lifted away from the core layer to form a tab that was clamped onto the upper jaw of the Instron machine.
- the wound- facing layer was then peeled off of the core layer at a 90-degree angle and at a crosshead speed of 300 mm/min.
- the peel force was recorded in grams force per 2.54-cm width as an average of three replications.
- a multi-layer absorbent wound dressing having a backing layer, a first absorbent layer, a second absorbent layer, and a wound- facing layer was prepared by the following procedure.
- the first absorbent layer precursor composition (Composition A) was prepared as follows. Acrylic acid (528 g, BASF, Mt. Olive, NJ), 50% (w/w) sodium hydroxide solution (99 g, J. T. Baker, Philipsburg, NJ), and 2-hydroxy-l-[4-(hydroxyethoxy)phenyl]- 2-methyl-l-propanone (1.32 g, Ciba Specialty Chemicals Co ⁇ ., Tarrytown, NY) were added to a glass jar and mixed until dissolved. Methoxypolyethyleneglycol 400 acrylate
- composition B The second absorbent layer precursor composition (Composition B) was prepared as follows. Acrylic acid (239 g), 50 (w/w) sodium hydroxide solution (41.6 g), and 2- hydroxy-l-[4-(hydroxyethoxy)phenyl]-2-methyl-l-propanone (1.3 g) were added to a glass jar and mixed until dissolved.
- Methoxypolyethyleneglycol 400 acrylate (1016 g) was added to the jar and mixed in by shaking the jar. While stirring the resulting solution with a propeller, 2-ethylhexyl acrylate (1951 g, BASF Co ⁇ .) was added to provide the finished composition.
- Compositions A and B were thickened separately to between 1000 and 2000 centipose by short exposure to UV light and an additional 3.25 g of 2-hydroxy-l-[4- (hydroxyethoxy)phenyl] -2-methyl- 1-propanone was added and mixed into each composition.
- the thickened Composition B was knife-coated at a thickness of 3 mil (.076 mm) onto a conventional polyester release liner, followed immediately by knife-coating of the thickened Composition A at a thickness of 25 mil (.635 mm) onto the Composition B layer.
- a conventional polyester release liner was provided on top of the Composition A layer.
- the coated layers were then cured under UV lamps (350BL, Sylvania Co ⁇ ., Danvers, MA) at a peak wavelength of 350 nm and an intensity of 7.3 mW/cm 2 and a dose of 2360 mJ/cm 2 through the top release liner to make the finished core laminate of the adhesive wound dressing. Additionally, the thickened Composition B was separately knife-coated at a thickness of 25 mil (.635 mm) onto a conventional polyester release liner for later testing.
- UV lamps 350BL, Sylvania Co ⁇ ., Danvers, MA
- a wound-facing layer was prepared by perforating a TEGADERMTM dressing (3M Company) by ultrasonic means so that the dressing contained 40 holes/cm 2 with each hole having a diameter of approximately 15 mils (0.38 mm).
- the Percent Void Area was calculated to be 4.5%.
- the release liner was removed from the Composition A layer (first absorbent layer) side of the core laminate and to this side was laminated by hand to the adhesive side of a TEGADERMTM dressing (backing layer). The release liner was then removed from the Composition A layer (first absorbent layer) side of the core laminate and to this side was laminated by hand to the adhesive side of a TEGADERMTM dressing (backing layer). The release liner was then removed from the Composition A layer (first absorbent layer) side of the core laminate and to this side was laminated by hand to the adhesive side of a TEGADERMTM dressing (backing layer). The release liner was then removed from the
- Composition B layer (second absorbent layer) side of the core laminate and to this side was laminated by hand to the non-adhesive side of the wound-facing layer.
- the resulting completed multi-layer absorbent wound dressing material was cut into 10-cm x 15-cm samples for test evaluations. Samples were also subsequently packaged and sterilized by irradiating at approximately 30 kGy.
- a multi-layer absorbent wound dressing was prepared as described in Example 1, except that N-vinyl acetamide was substituted for the acrylic acid/sodium hydroxide components in the first absorbent layer precursor composition (Composition A) and this composition was prepared as follows.
- N- Vinyl acetamide 600 g, Showa Denko, Japan
- 2-hydroxy-l-[4- (hydiOxyethoxy)phenyl]-2-methyl-l-propanone 1.2 g
- methoxypolyethyleneglycol 400 acrylate 2183 g
- Lauryl acrylate 210 g
- alpha-methylstyrene 3.0 g
- the wound-facing layer in this example contained 40 holes/cm 2 with each hole having a diameter of approximately 20 mils (0.51 mm).
- the Percent Void Area was calculated to be 7.8%.
- the resulting completed multi-layer absorbent wound dressing material was cut into 10-cm x 15-cm samples for test evaluations.
- a multi-layer absorbent wound dressing was prepared as described in Example 1, except that the sodium hydroxide solution component was not added to either Composition A or Composition B.
- the resulting completed multi-layer absorbent wound dressing material was cut into 10-cm x 15-cm samples for test evaluations.
- a multi-layer absorbent wound dressing was prepared as described in Example 1, except that the first absorbent layer precursor composition (Composition A) was prepared as follows! 2-Hydroxy-l-[4-(hydroxyethoxy)phenyl]-2-methyl-l-propanone (1.32 g) and methoxypolyethyleneglycol 400 acrylate (2995 g) were added to a glass jar and mixed by shaking the jar. Alpha-methylstyrene (3.3 g) was then added and the entire composition was mixed by shaking the jar. The resulting completed multi-layer absorbent wound dressing material was cut into 10-cm x 15-cm samples for test evaluations.
- Composition A 2-Hydroxy-l-[4-(hydroxyethoxy)phenyl]-2-methyl-l-propanone
- methoxypolyethyleneglycol 400 acrylate 2995 g
- Example 2 The results are provided in Table 2 and show that the invention wound dressing samples (Examples 1 and 4) had an increasing level of CBS absorbency between 24 and 72 hours, had a high level of absorbency (10 to 12 g) at 72 hours, and left no dressing sample residue in the test cell. In contrast, Comparative Example 1 (lacking a second absorbent layer) reached a maximum absorbency (12 g) before 24 hours and left sample residue in the test cell. Samples from Examples 1 and 4, and Comparative Example 1 showed significantly higher absorbency than the four commercial wound dressing samples.
- Example 1 and Comparative Example 1 were evaluated for peel force (the force required to separate the wound-facing layer from the core layer) according to the test method described herein.
- the results are provided in Table 3 and show that a much greater force was required to separate the wound- facing layer from the absorbent core layer (having a second absorbent layer) of the invention wound dressing (Example 1) than from the core layer (not having a second absorbent layer) of the comparative wound dressing (Comparative Example 1).
- Wound dressing samples from Examples 1-3 and Comparative Example 1 were evaluated for saline extract acidity according to the test method described herein.
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002524549A JP4927300B2 (en) | 2000-09-08 | 2001-08-28 | Multilayer absorbent wound dressing |
BR0113719-0A BR0113719A (en) | 2000-09-08 | 2001-08-28 | Multilayer wound dressing, and body fluid absorbent material. |
CA002420094A CA2420094A1 (en) | 2000-09-08 | 2001-08-28 | Multi-layer absorbent wound dressing |
AU8684501A AU8684501A (en) | 2000-09-08 | 2001-08-28 | Multi-layer absorbent wound dressing |
DE60124118T DE60124118T2 (en) | 2000-09-08 | 2001-08-28 | MULTILAYER ABSORBENT WING ASSOCIATION |
EP01966320A EP1315527B1 (en) | 2000-09-08 | 2001-08-28 | Multi-layer absorbent wound dressing |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/657,486 US6903243B1 (en) | 2000-09-08 | 2000-09-08 | Multi-layer absorbent wound dressing |
US09/657,486 | 2000-09-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002020067A2 true WO2002020067A2 (en) | 2002-03-14 |
WO2002020067A3 WO2002020067A3 (en) | 2002-07-04 |
Family
ID=24637376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/026791 WO2002020067A2 (en) | 2000-09-08 | 2001-08-28 | Multi-layer absorbent wound dressing |
Country Status (11)
Country | Link |
---|---|
US (2) | US6903243B1 (en) |
EP (1) | EP1315527B1 (en) |
JP (1) | JP4927300B2 (en) |
AT (1) | ATE343402T1 (en) |
AU (1) | AU8684501A (en) |
BR (1) | BR0113719A (en) |
CA (1) | CA2420094A1 (en) |
DE (1) | DE60124118T2 (en) |
ES (1) | ES2275723T3 (en) |
TW (1) | TWI288003B (en) |
WO (1) | WO2002020067A2 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1422058A1 (en) * | 2002-10-23 | 2004-05-26 | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | Adhesive bandage having an improved backing material |
DE10301835A1 (en) * | 2003-01-20 | 2004-07-29 | Beiersdorf Ag | Plaster for dressing wounds has clear fixing film and wound dressing with visible printing on side remote from wound, printed directly on dressing or as normal or mirror image on film bonded to dressing |
US7005143B2 (en) | 2002-04-12 | 2006-02-28 | 3M Innovative Properties Company | Gel materials, medical articles, and methods |
WO2007046969A2 (en) * | 2005-10-11 | 2007-04-26 | Kimberly-Clark Worldwide, Inc. | Transparent/translucent absorbent composites and articles |
WO2007067276A2 (en) * | 2005-12-02 | 2007-06-14 | Kimberly-Clark Worldwide, Inc. | Articles comprising transparent/translucent polymer composition |
WO2007118664A1 (en) * | 2006-04-12 | 2007-10-25 | Birgit Riesinger | Compress provided with a slit |
US7612248B2 (en) | 2002-12-19 | 2009-11-03 | 3M Innovative Properties Company | Absorbent medical articles |
WO2009091682A3 (en) * | 2008-01-18 | 2010-05-27 | 3M Innovative Properties Company | Hydrogels with tapered edge |
JP2010179131A (en) * | 2003-06-26 | 2010-08-19 | Zuiko Corp | Wound dressing and wound dressing kit |
US9204999B2 (en) | 2008-05-30 | 2015-12-08 | Kci Licensing, Inc. | See-through reduced-pressure dressings and system |
US9393158B2 (en) | 2011-08-25 | 2016-07-19 | Brightwake Limited | Non-adherent wound dressing |
US9457123B2 (en) | 2008-09-24 | 2016-10-04 | 3M Innovative Properties Company | Hydrogels with release element |
US10086107B2 (en) | 2006-04-03 | 2018-10-02 | Brightwake Limited | Adhesive laminates and applications thereof |
US10271995B2 (en) | 2012-12-18 | 2019-04-30 | Kci Usa, Inc. | Wound dressing with adhesive margin |
US10456497B2 (en) | 2014-09-10 | 2019-10-29 | C. R. Bard, Inc. | Protective dressing for skin-placed medical device |
US11426165B2 (en) | 2008-05-30 | 2022-08-30 | Kci Licensing, Inc. | Reduced-pressure, linear wound closing bolsters and systems |
WO2023091856A1 (en) * | 2021-11-17 | 2023-05-25 | Johnson & Johnson Consumer Inc. | Curable absorbent films |
US11969319B2 (en) | 2020-10-02 | 2024-04-30 | Solventum Intellectual Properties Company | Reduced-pressure, compression systems and apparatuses for use on a curved body part |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201907217T4 (en) * | 2002-05-29 | 2019-06-21 | Sekisui Chemical Co Ltd | Based blood test tube, spigot for blood test tube and blood test container. |
US7805768B2 (en) * | 2002-06-24 | 2010-10-05 | Christine Martz | Liquid penetration shields for outer garments |
GB2393655B (en) * | 2002-09-27 | 2005-08-24 | Johnson & Johnson Medical Ltd | Wound treatment device |
DE10316156B3 (en) * | 2003-04-09 | 2004-10-14 | Beiersdorf Ag | Antimicrobial polymer materials and their use as a wound dressing |
US20060142684A1 (en) * | 2003-04-11 | 2006-06-29 | Shanbrom Technologies, Llc | Oxygen releasing material |
DE10328261B4 (en) | 2003-06-23 | 2007-10-25 | Beiersdorf Ag | Disinfecting coating with silver coating and its use |
AU2004248898B2 (en) * | 2003-06-23 | 2010-03-18 | Beiersdorf Ag | Antimicrobial wounddressing |
DE602005022831D1 (en) * | 2004-02-13 | 2010-09-23 | Convatec Technologies Inc | MULTILAYER WOUND ASSOCIATION |
EP1824580A1 (en) * | 2004-10-26 | 2007-08-29 | Reemay, Inc. | Composite filtration media |
WO2006047093A1 (en) * | 2004-10-26 | 2006-05-04 | Reemay, Inc. | Composite fabric with controlled release of functional chemicals |
EP1855630A1 (en) * | 2005-02-24 | 2007-11-21 | Coloplast A/S | A wound dressing |
GB2432790A (en) * | 2005-12-01 | 2007-06-06 | David William Richardson | A wound dressing with active ingredients |
JP4874723B2 (en) * | 2006-06-26 | 2012-02-15 | 国防部軍備局中山科学研究院 | Silver nano medical poultice |
EP2036952B1 (en) * | 2006-06-30 | 2016-04-20 | Toray Industries, Inc. | Thermoplastic resin composition and molded article thereof |
ATE456383T1 (en) | 2006-09-28 | 2010-02-15 | Tyco Healthcare | PORTABLE WOUND THERAPY SYSTEM |
EP3170396A1 (en) | 2007-02-19 | 2017-05-24 | Plurogen Therapeutics, Inc. | Compositions for treating biofilms and methods for using same |
US7833577B2 (en) * | 2007-05-11 | 2010-11-16 | 3M Innovative Properties Company | Methods of making a pressure-sensitive adhesive assembly |
US7947027B2 (en) | 2007-12-28 | 2011-05-24 | Kimberly-Clark Worldwide, Inc. | Body adhering absorbent article |
US8734413B2 (en) | 2007-08-03 | 2014-05-27 | Kimberly-Clark Worldwide, Inc. | Packaged body adhering absorbent article |
US8672911B2 (en) | 2007-08-03 | 2014-03-18 | Kimberly-Clark Worldwide, Inc. | Body adhering absorbent article |
US8292862B2 (en) | 2007-08-03 | 2012-10-23 | Kimberly-Clark Worldwide, Inc. | Dynamic fitting body adhering absorbent article |
US11253399B2 (en) * | 2007-12-06 | 2022-02-22 | Smith & Nephew Plc | Wound filling apparatuses and methods |
US20130096518A1 (en) | 2007-12-06 | 2013-04-18 | Smith & Nephew Plc | Wound filling apparatuses and methods |
US9033942B2 (en) | 2008-03-07 | 2015-05-19 | Smith & Nephew, Inc. | Wound dressing port and associated wound dressing |
JP2011518222A (en) * | 2008-04-21 | 2011-06-23 | スリーエム イノベイティブ プロパティズ カンパニー | Nitric oxide releasing composition, device and method |
DE102008031183A1 (en) * | 2008-07-03 | 2010-01-07 | Paul Hartmann Ag | wound dressing |
US8454990B2 (en) * | 2008-08-01 | 2013-06-04 | Milliken & Company | Composite article suitable for use as a wound dressing |
AU2009293350B2 (en) * | 2008-09-18 | 2014-11-27 | Solventum Intellectual Properties Company | Multi-layer dressings, systems, and methods for applying reduced pressure at a tissue site |
DE102008053335B4 (en) * | 2008-10-27 | 2015-02-19 | Medi-Globe Gmbh | Association |
US8765217B2 (en) | 2008-11-04 | 2014-07-01 | Entrotech, Inc. | Method for continuous production of (meth)acrylate syrup and adhesives therefrom |
US11147722B2 (en) | 2008-11-10 | 2021-10-19 | Kimberly-Clark Worldwide, Inc. | Absorbent article with a multifunctional acrylate skin-adhesive composition |
GB0821702D0 (en) | 2008-11-28 | 2008-12-31 | Brightwake Ltd | Process |
TW201021867A (en) * | 2008-12-12 | 2010-06-16 | Ind Tech Res Inst | Fluid processing system and collecting device thereof |
DE102008062824A1 (en) * | 2008-12-23 | 2010-07-01 | Paul Hartmann Ag | wound dressing |
US10022468B2 (en) | 2009-02-02 | 2018-07-17 | Kimberly-Clark Worldwide, Inc. | Absorbent articles containing a multifunctional gel |
US8329079B2 (en) | 2009-04-20 | 2012-12-11 | Entrochem, Inc. | Method and apparatus for continuous production of partially polymerized compositions and polymers therefrom |
AU2010249574B2 (en) | 2009-05-19 | 2015-05-14 | Plurogen Therapeutics, Inc. | Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing |
US20100324516A1 (en) | 2009-06-18 | 2010-12-23 | Tyco Healthcare Group Lp | Apparatus for Vacuum Bridging and/or Exudate Collection |
MX2009007258A (en) * | 2009-07-03 | 2011-01-24 | Monterrey Inst Tecnologico Y De Estudios Superiores De | Suction compress. |
US20110033515A1 (en) * | 2009-08-04 | 2011-02-10 | Rst Implanted Cell Technology | Tissue contacting material |
US8690844B2 (en) * | 2009-08-27 | 2014-04-08 | Kci Licensing, Inc. | Re-epithelialization wound dressings and systems |
WO2011087871A2 (en) | 2009-12-22 | 2011-07-21 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
EP2338529B1 (en) | 2009-12-24 | 2013-05-29 | Paul Hartmann AG | Hydrogel matrix with improved adhesive characteristics |
EP2338447A1 (en) * | 2009-12-28 | 2011-06-29 | Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO | A preparing process and a disinfecting bandage |
USRE48117E1 (en) | 2010-05-07 | 2020-07-28 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
CN103025322B (en) * | 2010-07-12 | 2014-07-23 | 东洋纺株式会社 | Patch support for water-based plaster |
TWI568422B (en) | 2010-07-12 | 2017-02-01 | 帝國製藥股份有限公司 | Support having trilaminar structure and aqueous patch with the support |
USD714433S1 (en) | 2010-12-22 | 2014-09-30 | Smith & Nephew, Inc. | Suction adapter |
US9050398B2 (en) | 2010-12-22 | 2015-06-09 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
GB201108229D0 (en) * | 2011-05-17 | 2011-06-29 | Smith & Nephew | Tissue healing |
US9237969B2 (en) * | 2011-07-28 | 2016-01-19 | Matthew D. Antalek | Wound barrier pad |
US10179186B2 (en) | 2012-06-29 | 2019-01-15 | Ansell Limited | Wound care articles |
PL2740449T3 (en) | 2012-12-10 | 2019-07-31 | The Procter & Gamble Company | Absorbent article with high absorbent material content |
RU2649546C2 (en) | 2013-08-27 | 2018-04-03 | Дзе Проктер Энд Гэмбл Компани | Absorbent articles with channels |
US9987176B2 (en) | 2013-08-27 | 2018-06-05 | The Procter & Gamble Company | Absorbent articles with channels |
US10182945B2 (en) | 2013-10-04 | 2019-01-22 | Dristi, LLC | Hybrid dressings of hydrophilic material and polymer foam |
WO2016118644A1 (en) | 2015-01-20 | 2016-07-28 | Plurogen Therapeutics, Llc | Compositions and methods of treating microbes |
EP3106139A1 (en) | 2015-06-17 | 2016-12-21 | 3M Innovative Properties Company | Fire wound dressing with polyamide membrane |
WO2018226691A1 (en) | 2017-06-07 | 2018-12-13 | Kci Licensing, Inc. | Methods for manufacturing and assembling dual material tissue interface for negative-pressure therapy |
EP3634519B1 (en) | 2017-06-07 | 2023-05-31 | 3M Innovative Properties Company | Systems, apparatuses, and methods for negative-pressure treatment with reduced tissue in-growth |
JP2020523078A (en) * | 2017-06-07 | 2020-08-06 | ケーシーアイ ライセンシング インコーポレイテッド | Composite dressing for promoting granulation and reducing maceration by negative pressure treatment |
CN110709038B (en) | 2017-06-07 | 2022-09-02 | 3M创新知识产权公司 | Composite dressing for improving granulation growth and reducing maceration by negative pressure therapy |
KR20200016929A (en) | 2017-06-07 | 2020-02-17 | 케이씨아이 라이센싱 인코포레이티드 | Composite dressing for improving childcare and reducing smoke by using negative pressure treatment |
AU2018281120A1 (en) | 2017-06-07 | 2020-01-02 | 3M Innovative Properties Company | Peel and place dressing for negative-pressure treatment |
JP2020523077A (en) | 2017-06-07 | 2020-08-06 | ケーシーアイ ライセンシング インコーポレイテッド | Composite dressing for promoting granulation and reducing maceration by negative pressure treatment |
GB201811449D0 (en) | 2018-07-12 | 2018-08-29 | Smith & Nephew | Apparatuses and methods for negative pressure wound therapy |
KR102633741B1 (en) * | 2021-08-05 | 2024-02-06 | 주식회사 영우 | Dressing material with excellent adhesion and absorption |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997019116A1 (en) * | 1995-11-21 | 1997-05-29 | Stockhausen Gmbh & Co. Kg | Fluid-absorbing polymers, process for the preparation and use thereof |
WO1997018890A1 (en) * | 1995-11-21 | 1997-05-29 | Stockhausen Gmbh & Co. Kg | Water-absorbing polymers with improved properties, process for the preparation and use thereof |
WO1999032272A1 (en) * | 1997-12-19 | 1999-07-01 | Kimberly-Clark Worldwide, Inc. | Microporous films having zoned breathability |
EP0997539A2 (en) * | 1988-12-02 | 2000-05-03 | Rohm And Haas Company | Aqueous dispersion of copolymer for leather treatment |
WO2001060296A1 (en) * | 2000-02-15 | 2001-08-23 | 3M Innovative Properties Company | Textured absorbent article for wound dressing |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT610737A (en) | 1955-11-18 | 1900-01-01 | ||
US3339549A (en) | 1959-11-02 | 1967-09-05 | Johnson & Johnson | Sanitary napkin with knitted wrapper |
US3121021A (en) | 1960-04-18 | 1964-02-11 | Minnesota Mining & Mfg | Breathable surgical adhesive tapes |
US4112213A (en) | 1964-09-28 | 1978-09-05 | Johnson & Johnson | Pressure sensitive adhesive tapes and method of making same |
US3419006A (en) | 1966-08-08 | 1968-12-31 | Union Carbide Corp | Novel dressing and use thereof |
US3389827A (en) | 1967-04-10 | 1968-06-25 | Minnesota Mining & Mfg | Easy-open container and sealing tape |
US3595235A (en) * | 1969-05-16 | 1971-07-27 | Georgia Pacific Corp | Multilayer absorbent pad |
US4181752A (en) | 1974-09-03 | 1980-01-01 | Minnesota Mining And Manufacturing Company | Acrylic-type pressure sensitive adhesives by means of ultraviolet radiation curing |
US4146027A (en) * | 1976-09-24 | 1979-03-27 | Rohm And Haas Company | Method for dressing a wound |
US4310509A (en) | 1979-07-31 | 1982-01-12 | Minnesota Mining And Manufacturing Company | Pressure-sensitive adhesive having a broad spectrum antimicrobial therein |
US4323557A (en) | 1979-07-31 | 1982-04-06 | Minnesota Mining & Manufacturing Company | Pressure-sensitive adhesive containing iodine |
US4324246A (en) | 1980-05-12 | 1982-04-13 | The Procter & Gamble Company | Disposable absorbent article having a stain resistant topsheet |
US5445604A (en) | 1980-05-22 | 1995-08-29 | Smith & Nephew Associated Companies, Ltd. | Wound dressing with conformable elastomeric wound contact layer |
US4860737A (en) | 1981-02-13 | 1989-08-29 | Smith And Nephew Associated Companies P.L.C. | Wound dressing, manufacture and use |
US4499896A (en) | 1982-03-30 | 1985-02-19 | Minnesota Mining And Manufacturing Co. | Reservoir wound dressing |
US4595001A (en) | 1982-04-08 | 1986-06-17 | Smith And Nephew Associated Companies P.L.C. | Surgical adhesive dressing |
GR79380B (en) | 1982-09-28 | 1984-10-22 | Johnson & Johnson Prod Inc | |
DE3464326D1 (en) | 1983-04-06 | 1987-07-30 | Smith & Nephew Ass | Dressing |
GB8309993D0 (en) | 1983-04-13 | 1983-05-18 | Smith & Nephew Ass | Surgical adhesive dressing |
US4667665A (en) | 1984-08-16 | 1987-05-26 | Colin O'D. Offenhartz | Non-occlusive burn and trauma dressing |
US4904247A (en) * | 1984-08-31 | 1990-02-27 | Kendall Company | Pressure-sensitive hydrophilic laminate structures for use in wound dressing, transdermal and topical drug delivery |
US4598004A (en) | 1985-01-24 | 1986-07-01 | Minnesota Mining And Manufacturing Company | Thin film surgical dressing with delivery system |
US4755413A (en) | 1986-05-22 | 1988-07-05 | Chicopee | Apertured film facing and method of making the same |
US4684558A (en) | 1986-06-30 | 1987-08-04 | Nepera Inc. | Adhesive polyethylene oxide hydrogel sheet and its production |
US5147698A (en) * | 1986-09-30 | 1992-09-15 | Minnesota Mining And Manufacturing Company | Pressure sensitive adhesive film article having high moisture vapor transmission rate |
US4909244B1 (en) | 1986-11-26 | 1994-07-05 | Kendall & Co | Hydrogel wound dressing |
US4737410A (en) | 1986-11-28 | 1988-04-12 | Minnesota Mining And Manufacturing Company | Polyalkyloxazoline-reinforced acrylic pressure-sensitive adhesive composition |
US4867150A (en) * | 1987-01-20 | 1989-09-19 | The B. F. Goodrich Company | Perforated elastomeric soft film and wound dressing made therewith |
US4784653A (en) | 1987-06-22 | 1988-11-15 | Johnson & Johnson Patient Care, Inc. | Absorbent adhesive dressing |
US4935087A (en) | 1987-12-14 | 1990-06-19 | The Kendall Company | Method of making an absorbent dressing |
US4979946A (en) | 1987-12-14 | 1990-12-25 | The Kendall Company | Environmental absorbent dressing |
US5106629A (en) * | 1989-10-20 | 1992-04-21 | Ndm Acquisition Corp. | Transparent hydrogel wound dressing |
US5059424A (en) | 1989-11-01 | 1991-10-22 | Ndm Acquisition Corp. | Hydrogel wound dressing product |
US5270111A (en) * | 1990-09-10 | 1993-12-14 | Minnesota Mining And Manufacturing Company | Water-dispersible pressure sensitive adhesive tape |
JPH04346920A (en) * | 1991-05-21 | 1992-12-02 | Nitto Denko Corp | Functional external preparation |
DK5492A (en) | 1992-01-17 | 1993-07-18 | Coloplast As | A dressing |
NZ248977A (en) | 1992-11-09 | 1995-06-27 | Squibb & Sons Inc | Pressure-sensitive adhesive comprising a polyurethane having excess hydroxyl functionality; medical articles comprising a layer of such adhesive |
US5429590A (en) | 1992-12-01 | 1995-07-04 | Nitto Denko Corporation | Medical water-absorptive polymer and dressing for wound and medical bandage using the same |
AU674546B2 (en) | 1992-12-15 | 1997-01-02 | Johnson & Johnson Consumer Products, Inc. | Hydrogel laminate, bandages and composites and methods for forming the same |
CA2157040C (en) | 1993-03-22 | 2007-12-11 | Steven B. Heinecke | Windowless frame delivered dressing and method of manufacture |
JPH06315525A (en) * | 1993-05-07 | 1994-11-15 | Nitto Denko Corp | Water-absorptive polymer laminate for medical use and coating material for wound by using the same |
JPH0833672A (en) * | 1994-07-22 | 1996-02-06 | Terumo Corp | Wound coating material |
GB9421653D0 (en) | 1994-10-27 | 1994-12-14 | Innovative Tech Ltd | Wound dressing |
US5614310A (en) | 1994-11-04 | 1997-03-25 | Minnesota Mining And Manufacturing Company | Low trauma wound dressing with improved moisture vapor permeability |
DE19529348C2 (en) | 1995-08-09 | 1997-11-20 | Stockhausen Chem Fab Gmbh | Absorbent for water and aqueous liquids based on polyacrylate and process for their production and use |
US5968001A (en) | 1996-05-14 | 1999-10-19 | Bristol-Myers Squibb Company | Wound dressings with leak prevention seal |
US5733570A (en) | 1996-09-05 | 1998-03-31 | Minnesota Mining And Manufacturing Company | Absorbent dressing |
US5849325A (en) | 1996-10-07 | 1998-12-15 | Minnesota Mining And Manufacturing Company | Moisture-regulating adhesive dressing |
GB9701178D0 (en) | 1997-01-21 | 1997-03-12 | Smith & Nephew | Dressings |
GB2324732B (en) | 1997-05-02 | 2001-09-26 | Johnson & Johnson Medical | Absorbent wound dressings |
GB9717357D0 (en) | 1997-08-16 | 1997-10-22 | Bristol Myers Squibb Co | Multi layered wound dressing |
FR2768341B1 (en) | 1997-09-18 | 2000-04-14 | Lab Francais Du Fractionnement | LYOPHILISABLE PLACEBO PHARMACEUTICAL COMPOSITION FOR IMITATING A MEDICAMENT, IN PARTICULAR BASED ON PROTEINS OR POLYPEPTIDES |
EP1014946B1 (en) | 1997-09-18 | 2010-04-07 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
US6171985B1 (en) | 1997-12-01 | 2001-01-09 | 3M Innovative Properties Company | Low trauma adhesive article |
US6254990B1 (en) * | 1998-02-18 | 2001-07-03 | Nippon Shokubai Co., Ltd. | Surface-crosslinking process for water-absorbent resin |
US6198016B1 (en) | 1998-12-01 | 2001-03-06 | 3M Innovative Properties Company | Wet skin adhesive article |
-
2000
- 2000-09-08 US US09/657,486 patent/US6903243B1/en not_active Expired - Lifetime
-
2001
- 2001-08-27 TW TW090121066A patent/TWI288003B/en not_active IP Right Cessation
- 2001-08-28 ES ES01966320T patent/ES2275723T3/en not_active Expired - Lifetime
- 2001-08-28 CA CA002420094A patent/CA2420094A1/en not_active Abandoned
- 2001-08-28 WO PCT/US2001/026791 patent/WO2002020067A2/en active IP Right Grant
- 2001-08-28 JP JP2002524549A patent/JP4927300B2/en not_active Expired - Fee Related
- 2001-08-28 AT AT01966320T patent/ATE343402T1/en not_active IP Right Cessation
- 2001-08-28 DE DE60124118T patent/DE60124118T2/en not_active Expired - Lifetime
- 2001-08-28 BR BR0113719-0A patent/BR0113719A/en not_active Application Discontinuation
- 2001-08-28 AU AU8684501A patent/AU8684501A/en not_active Withdrawn
- 2001-08-28 EP EP01966320A patent/EP1315527B1/en not_active Expired - Lifetime
-
2005
- 2005-06-06 US US11/145,867 patent/US20050226917A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0997539A2 (en) * | 1988-12-02 | 2000-05-03 | Rohm And Haas Company | Aqueous dispersion of copolymer for leather treatment |
WO1997019116A1 (en) * | 1995-11-21 | 1997-05-29 | Stockhausen Gmbh & Co. Kg | Fluid-absorbing polymers, process for the preparation and use thereof |
WO1997018890A1 (en) * | 1995-11-21 | 1997-05-29 | Stockhausen Gmbh & Co. Kg | Water-absorbing polymers with improved properties, process for the preparation and use thereof |
WO1999032272A1 (en) * | 1997-12-19 | 1999-07-01 | Kimberly-Clark Worldwide, Inc. | Microporous films having zoned breathability |
WO2001060296A1 (en) * | 2000-02-15 | 2001-08-23 | 3M Innovative Properties Company | Textured absorbent article for wound dressing |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7005143B2 (en) | 2002-04-12 | 2006-02-28 | 3M Innovative Properties Company | Gel materials, medical articles, and methods |
EP1422058A1 (en) * | 2002-10-23 | 2004-05-26 | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | Adhesive bandage having an improved backing material |
US7612248B2 (en) | 2002-12-19 | 2009-11-03 | 3M Innovative Properties Company | Absorbent medical articles |
US8410332B2 (en) | 2002-12-19 | 2013-04-02 | 3M Innovative Properties Company | Absorbent medical articles |
DE10301835A1 (en) * | 2003-01-20 | 2004-07-29 | Beiersdorf Ag | Plaster for dressing wounds has clear fixing film and wound dressing with visible printing on side remote from wound, printed directly on dressing or as normal or mirror image on film bonded to dressing |
JP2013013743A (en) * | 2003-06-26 | 2013-01-24 | Zuiko Corp | Wound dressing and wound dressing kit |
JP2010179131A (en) * | 2003-06-26 | 2010-08-19 | Zuiko Corp | Wound dressing and wound dressing kit |
WO2007046969A3 (en) * | 2005-10-11 | 2008-04-03 | Kimberly Clark Co | Transparent/translucent absorbent composites and articles |
WO2007046969A2 (en) * | 2005-10-11 | 2007-04-26 | Kimberly-Clark Worldwide, Inc. | Transparent/translucent absorbent composites and articles |
WO2007067276A3 (en) * | 2005-12-02 | 2008-04-10 | Kimberly Clark Co | Articles comprising transparent/translucent polymer composition |
WO2007067276A2 (en) * | 2005-12-02 | 2007-06-14 | Kimberly-Clark Worldwide, Inc. | Articles comprising transparent/translucent polymer composition |
US10086107B2 (en) | 2006-04-03 | 2018-10-02 | Brightwake Limited | Adhesive laminates and applications thereof |
WO2007118664A1 (en) * | 2006-04-12 | 2007-10-25 | Birgit Riesinger | Compress provided with a slit |
US9242022B2 (en) * | 2008-01-18 | 2016-01-26 | 3M Innovative Properties Company | Hydrogels with tapered edge |
WO2009091682A3 (en) * | 2008-01-18 | 2010-05-27 | 3M Innovative Properties Company | Hydrogels with tapered edge |
US11426165B2 (en) | 2008-05-30 | 2022-08-30 | Kci Licensing, Inc. | Reduced-pressure, linear wound closing bolsters and systems |
US11419768B2 (en) | 2008-05-30 | 2022-08-23 | Kci Licensing, Inc. | Reduced pressure, compression systems and apparatuses for use on joints |
US11793679B2 (en) | 2008-05-30 | 2023-10-24 | Kci Licensing, Inc. | Super-absorbent, reduced-pressure wound dressing and systems |
US9204999B2 (en) | 2008-05-30 | 2015-12-08 | Kci Licensing, Inc. | See-through reduced-pressure dressings and system |
US11413193B2 (en) | 2008-05-30 | 2022-08-16 | Kci Licensing, Inc. | Dressing assemblies for wound treatment using reduced pressure |
US11020277B2 (en) | 2008-05-30 | 2021-06-01 | Kci Licensing, Inc. | Reduced-pressure, compression systems and apparatuses for use on a curved body part |
US11382796B2 (en) | 2008-05-30 | 2022-07-12 | Kci Licensing, Inc. | Reduced-pressure surgical wound treatment systems and methods |
US9457123B2 (en) | 2008-09-24 | 2016-10-04 | 3M Innovative Properties Company | Hydrogels with release element |
EP2365831B2 (en) † | 2008-09-24 | 2017-01-04 | 3M Innovative Properties Company | Hydrogels with release element |
US9393158B2 (en) | 2011-08-25 | 2016-07-19 | Brightwake Limited | Non-adherent wound dressing |
US10271995B2 (en) | 2012-12-18 | 2019-04-30 | Kci Usa, Inc. | Wound dressing with adhesive margin |
US11141318B2 (en) | 2012-12-18 | 2021-10-12 | KCl USA, INC. | Wound dressing with adhesive margin |
US10456497B2 (en) | 2014-09-10 | 2019-10-29 | C. R. Bard, Inc. | Protective dressing for skin-placed medical device |
US11969319B2 (en) | 2020-10-02 | 2024-04-30 | Solventum Intellectual Properties Company | Reduced-pressure, compression systems and apparatuses for use on a curved body part |
WO2023091856A1 (en) * | 2021-11-17 | 2023-05-25 | Johnson & Johnson Consumer Inc. | Curable absorbent films |
Also Published As
Publication number | Publication date |
---|---|
WO2002020067A3 (en) | 2002-07-04 |
ES2275723T3 (en) | 2007-06-16 |
CA2420094A1 (en) | 2002-03-14 |
AU8684501A (en) | 2002-03-22 |
JP2004515267A (en) | 2004-05-27 |
JP4927300B2 (en) | 2012-05-09 |
EP1315527A2 (en) | 2003-06-04 |
DE60124118D1 (en) | 2006-12-07 |
EP1315527B1 (en) | 2006-10-25 |
US20050226917A1 (en) | 2005-10-13 |
ATE343402T1 (en) | 2006-11-15 |
TWI288003B (en) | 2007-10-11 |
US6903243B1 (en) | 2005-06-07 |
BR0113719A (en) | 2003-07-29 |
DE60124118T2 (en) | 2007-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6903243B1 (en) | Multi-layer absorbent wound dressing | |
EP1572254B1 (en) | Absorbent medical articles | |
EP1263366B2 (en) | Textured absorbent article for wound dressing | |
US7005143B2 (en) | Gel materials, medical articles, and methods | |
EP0601463A1 (en) | Medical water-absorptive polymer and dressing for wound and medical bandage using the same | |
EP0825843A1 (en) | Spyrosorbent wound dressings for exudate management | |
AU2001286845B2 (en) | Multi-layer absorbent wound dressing | |
JP3220700B2 (en) | Medical water-absorbing polymer, wound dressing and medical external material using the same, and method for producing them | |
AU2001286845A1 (en) | Multi-layer absorbent wound dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001966320 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2420094 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002524549 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001286845 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2001966320 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWG | Wipo information: grant in national office |
Ref document number: 2001966320 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001286845 Country of ref document: AU |